SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Myriad Genetics, Inc. Hires JPMorgan to Explore Splitting Business

August 20, 2008 | 
1 min read
Aug. 19 (Bloomberg) -- Myriad Genetics Inc. hired the investment bank JPMorgan Chase & Co. to explore separating Myriad's drug-development and genetic-testing businesses after its experimental treatment for Alzheimer's disease failed.
Mergers & acquisitions People
MORE ON THIS TOPIC
Business negotiation, deal making or acquisition, merger vector concept. Two men shaking hands. Minimal design. Eps10 illustration
Immunology and inflammation
Sanofi pays Regeneron $1B upfront to continue search for Dupixent successor
October 1, 2026
 · 
3 min read
 · 
Tristan Manalac
A closed sign hanging on the door of a business
Manufacturing
BioNTech to close German manufacturing plants after failing to find buyers
September 30, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Save money and investment concept. Closeup piggy bank and silver coins falling. 3d rendering illustration
Business
Summit snags $2B investment from AstraZeneca, clearing financial overhang
September 29, 2026
 · 
3 min read
 · 
Tristan Manalac
Businessman standing on the top of the mountain adventure go to goal. vector illustrator
China
Novo adds long-term obesity differentiation in up to $2.6B Hengrui deal
September 29, 2026
 · 
2 min read
 · 
Annalee Armstrong